Patient Education
Europe Approves First-line Immunotherapy for Advanced Anal Cancer
New progress for advanced anal cancer in Europe. The European Commission has approved retifanlimab with chemotherapy as a first-line treatment, hel...
BATTMAN Trial Targets Breakthrough in Hard-to-Treat Colorectal Cancer
A new Phase III trial, BATTMAN, explores combination immunotherapy for MSS metastatic colorectal cancer, a group with limited options. By targeting...
Breakthroughs, Reality Checks, and New Directions in HBP Cancer Care
The annual American Society of Clinical Oncology – Gastrointestinal (ASCO-GI) meeting highlighted a major shift in treating Hepato-Bilio-Panc...
Expanding the Biomarker Landscape on Gastric Cancer
New research presented at the 2026 ASCO GI meeting shows that understanding the biology of gastric and gastroesophageal cancers is driving more per...
UK eoCRC Consortium: Collaboration, Funding and Patient Voices in Edinburgh
On 11 November, the UK Early-Onset Colorectal Cancer Consortium (eoCRCC) held its third in-person meeting in Edinburgh, bringing together more than...
Progress in Pancreatic Cancer: Highlights from ESMO 2025
New data from ESMO 2025 bring fresh hope in pancreatic cancer treatment, featuring advances in KRAS G12D-targeted therapy (GFH375), antibody–drug...
Supporting Your Mind: A Patient Guide Through Digestive Cancer
DiCE’s new guide offers practical tools to help patients manage the emotional impact of digestive cancer. Developed with patients, caregivers, an...
Personalised Progress in Gastric Cancer: Highlights from ESMO 2025
This year at ESMO, new research revealed improved methods to personalise treatment for gastric cancer. These approaches could help patients achieve...
ILCM Patient Charter: A Global Call for Liver Cancer Rights
We proudly support the International Liver Cancer Movement (ILCM) and its first global Patient Charter for Hepatocellular Carcinoma (HCC). Together...
From Plans to Patients: Are EU Cancer Screening and NCD Policies Delivering?
Are EU cancer screening and prevention policies truly reaching patients? We assess the progress of Europe’s Beating Cancer Plan and the SANT Comm...